S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
The "King Of Quants" sees 10X potential... (Ad)
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
The "King Of Quants" sees 10X potential... (Ad)
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
The "King Of Quants" sees 10X potential... (Ad)
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
The "King Of Quants" sees 10X potential... (Ad)
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
NASDAQ:ARCC

Ares Capital - ARCC Options Chain & Prices

$17.75
-0.08 (-0.45%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.69
▼
$17.85
50-Day Range
$17.19
▼
$20.04
52-Week Range
$16.53
▼
$22.65
Volume
2.28 million shs
Average Volume
4.39 million shs
Market Capitalization
$9.67 billion
P/E Ratio
14.79
Dividend Yield
10.82%
Price Target
$20.71

ARCC Put and Call Options List

Export to Excel
ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades
4/21/2023$16.00$0.075Put11513457
(+0)		33.33%
(-3.16%)		-0.1016025
4/21/2023$17.00$0.224Put39141311585
(+0)		29.59%
(-0.98%)		-0.26536818
4/21/2023$17.00$1.008Call1311156
(-2)		29.59%
(-0.98%)		0.7352374
4/21/2023$18.00$0.573Put20 - - 5267
(+0)		24.90%
(+1.08%)		-0.5659491
4/21/2023$18.00$0.356Call1087341533
(+39)		24.90%
(+1.08%)		0.43886217
4/21/2023$19.00$1.282Put86 - 1074
(-30)		21.11%
(-0.57%)		-0.9008564
4/21/2023$19.00$0.053Call49 - 222824
(-17)		21.11%
(-0.57%)		0.11757610
4/21/2023$20.00$0.025Call1 - - 2039
(-4)		27.28%
(+1.53%)		0.0511181
End-of-day options data provided by Trade Alert and Intrinio.

This page (NASDAQ:ARCC) was last updated on 3/29/2023 by MarketBeat.com Staff